Comparison

Empagliflozin (BI-10773)

Item no. DCC-DC5018-250mg
Manufacturer DCChemicals
CASRN 864070-44-0
Amount 250 mg
Quantity options 100 mg 10 mM x 1 ml in DMSO 1 g 250 mg
Category
Type Inhibitors
Specific against other
Purity >98%
Smiles ClC1C([H])=C([H])C(=C([H])C=1C([H])([H])C1C([H])=C([H])C(=C([H])C=1[H])O[C@]1([H])C([H])([H])OC([H])([H])C1([H])[H])[C@@]1([H])[C@@]([H])([C@]([H])([C@@]([H])([C@@]([H])(C([H])([H])O[H])O1)O[H])O[H])O[H]
ECLASS 10.1 32160490
ECLASS 11.0 32160490
UNSPSC 12000000
Alias BI-10773;BI 10773;BI10773
Similar products 864070-44-0
Available
Manufacturer - Applications
Empagliflozin is a potent, selective sodium glucose co-transporter-2 inhibitor that is in development for the treatment of type 2 diabetes. Empagliflozin is an inhibitor of the sodium glucose co-transporter-2 (SGLT-2), which is found almost exclusively in
Storage Conditions
2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO
Molecular Weight
450, 9093
Note
For research only, not for human use!

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 250 mg
Available: In stock
available

Delivery expected until 11/13/2025 

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close